CM&R Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Medicine & Research
Volume 2, Number 3 : 181 -187
doi:
© 2004 Marshfield Clinic
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibot, S.
Right arrow Articles by Cravoisy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibot, S.
Right arrow Articles by Cravoisy, A.


Review

Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection

Sébastien Gibot, MD

Service de Réanimation Médicale, Nancy, France

Aurélie Cravoisy, MD

Service de Réanimation Médicale, Nancy, France

REPRINT REQUESTS: Sébastien Gibot, MD, Service de Réanimation Médicale, 29 avenue du Maréchal de Latttre de Tassigny, 54000 Nancy, France, Telephone: +33-3-83852970, Fax: +33-3-83858511, Email: s.gibot{at}chu-nancy.fr

Sepsis is a common cause of morbidity and mortality in intensive care units. Unfortunately, there is no gold standard for diagnosing sepsis as clinical and laboratory signs are neither sensitive enough nor specific enough, and microbiological studies often remain negative. Thus, there is a need for clinical or laboratory tools to distinguish between sepsis and non-infectious inflammatory disorders. Among the potentially useful markers of sepsis, procalcitonin has been suggested to be the most promising, although results are variable depending on the severity of illness and degree of infection in the patient population studied. The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, of which expression is upregulated on phagocytic cells in the presence of bacteria or fungi. Here we report on the potential usefulness of assessing the soluble form of TREM-1 (sTREM-1) in biological fluids for the diagnosis of microbial infection.


Key Words: Sepsis • Infection • Community-acquired infections • Membrane glycoproteins • C-reactive protein • Protein precursors • Predictive value of tests • Inflammation/diagnosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Ornatowska, A. C. Azim, X. Wang, J. W. Christman, L. Xiao, M. Joo, and R. T. Sadikot
Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1377 - L1384.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Gomez-Pina, A. Soares-Schanoski, A. Rodriguez-Rojas, C. del Fresno, F. Garcia, M. T. Vallejo-Cremades, I. Fernandez-Ruiz, F. Arnalich, P. Fuentes-Prior, and E. Lopez-Collazo
Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human Monocytes
J. Immunol., September 15, 2007; 179(6): 4065 - 4073.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Christ-Crain and B. Muller
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators
Eur. Respir. J., September 1, 2007; 30(3): 556 - 573.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Haselmayer, L. Grosse-Hovest, P. von Landenberg, H. Schild, and M. P. Radsak
TREM-1 ligand expression on platelets enhances neutrophil activation
Blood, August 1, 2007; 110(3): 1029 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. F. Fortin, O. Lesur, and T. Fulop Jr
Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4
Int. Immunol., January 1, 2007; 19(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. G. Netea, T. Azam, G. Ferwerda, S. E. Girardin, S.-H. Kim, and C. A. Dinarello
Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors
J. Leukoc. Biol., December 1, 2006; 80(6): 1454 - 1461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Gattis, A. V. Washington, M. M. Chisholm, L. Quigley, A. Szyk, D. W. McVicar, and J. Lubkowski
The Structure of the Extracellular Domain of Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 and Evidence for a Naturally Occurring Soluble Fragment
J. Biol. Chem., May 12, 2006; 281(19): 13396 - 13403.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. M. Bianchin, J. E. Lima, J. Natel, A. C. Sakamoto, H. Klunemann, B.H. Ridha, L. Magy, J.R. Wherrett, D.M. Hemelsoet, R.W. Keen, et al.
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Neurology, February 28, 2006; 66(4): 615 - 616.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by Marshfield Clinic.